Heart
K |
K |
||
| Zeile 10: | Zeile 10: | ||
{{tp|p=32252591|t=2020. COVID-19 and the Heart |pdf=|usr=}} | {{tp|p=32252591|t=2020. COVID-19 and the Heart |pdf=|usr=}} | ||
{{tp|p=32363334|t=ä. Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) |pdf=|usr=}} | {{tp|p=32363334|t=ä. Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) |pdf=|usr=}} | ||
| − | |||
{{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}} | {{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}} | ||
{{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}} | {{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}} | ||
{{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}} | {{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}} | ||
{{tp|p=32247212|t=2020. Cardiovascular disease and COVID-19 |pdf=|usr=}} | {{tp|p=32247212|t=2020. Cardiovascular disease and COVID-19 |pdf=|usr=}} | ||
| + | {{tp|p=32363381|t=ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?|pdf=|usr=}} | ||
| + | {{tp|p=32227076|t=ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 |pdf=|usr=}} | ||
| + | {{tp|p=32196087|t=ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?|pdf=|usr=}} | ||
| + | {{tp|p=32267502|t=ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection |pdf=|usr=}} | ||
| + | {{tp|p=32267494|t=ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic |pdf=|usr=}} | ||
| + | {{tp|p=32285920|t=ä. Transient complete heart block in a patient with critical COVID-19 |pdf=|usr=}} | ||
| + | {{tp|p=32285915|t=ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection |pdf=|usr=}} | ||
| + | {{tp|p=32338706|t=ä. Myocarditis revealing COVID-19 infection in a young patient |pdf=|usr=}} | ||
| + | {{tp|p=32282027|t=ä. COVID-19-related myocarditis in a 21-year-old female patient |pdf=|usr=}} | ||
| + | {{tp|p=32359887|t=ä. SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade |pdf=|usr=}} | ||
Version vom 21. Mai 2020, 11:55 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
32281055 ä. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
32360119 ä. COVID-19 myopericarditis: It should be kept in mind in today s conditions
32317203 ä. Cardiovascular complications in COVID-19
32251498 ä. Hypertension and COVID-19
32209811 2020. Angiotensin II for the Treatment of COVID-19?Related Vasodilatory Shock
32303363 ä. ...impact sur le systeme cardiovasculaire...
32344395 2020. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection
32252591 2020. COVID-19 and the Heart
32363334 ä. Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO)
32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32331780 ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
32318865 2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
32247212 2020. Cardiovascular disease and COVID-19
32363381 ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?
32227076 ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19
32196087 ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?
32267502 ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection
32267494 ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic
32285920 ä. Transient complete heart block in a patient with critical COVID-19
32285915 ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection
32338706 ä. Myocarditis revealing COVID-19 infection in a young patient
32282027 ä. COVID-19-related myocarditis in a 21-year-old female patient
32359887 ä. SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade
